Anti-Sialyl 6,6'-disulfo LacNAc Monoclonal Antibody (G270-16)1vial

2-(4-cyclopropyl-6-oxopyrimidin-1(6H)-yl)acetic acid, 95.0%, 500mg

(E)-1,1,1-Trifluoro-4-phenylbut-3-en-2-ol, 98%, 1g

Ethyl 2-((tert-butoxycarbonyl)amino)thiazole-5-carboxylate, 95.0%, 1g

(E)-N'-((1H-indol-6-yl)methylene)-2-(2,4-dimethyl-6-(tetrahydro-2H-pyran-4-yl)phenoxy)acetohydrazide, 98%, 100mg

2-((4,5-Diphenyloxazol-2-yl)thio)-N-isobutylpropanamide, 97.0%, 250mg

6-Bromo-5-methoxypicolinaldehyde, 95.0%, 5g

Dibenzyl malonate, 95.0%, 500g

4,4-Dimethyl-3-oxo-pentanenitrile, 99.0%, 25g

4-Methylpiperazine-1-carboxylic acid hydrochloride, 97.0%, 250mg

(7R,8aS)-1,2,3,4,6,7,8,8a-octahydropyrrolo[1,2-a]pyrazin-7-ol dihydrochloride, 98%, 100mg

tert-Butyl (2-methylpiperidin-3-yl)carbamate, 95.0%, 1g

8-Methylcinnolin-4-amine, 98%, 250mg